Depression: EU approves expanded use of esketamine for rapid reduction of symptoms
BMJ
.
2021 Feb 10:372:n398.
doi: 10.1136/bmj.n398.
Author
Elisabeth Mahase
1
Affiliation
1
The BMJ.
PMID:
33568423
DOI:
10.1136/bmj.n398
No abstract available